These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37313727)

  • 21. [Surveillance for respiratory syncytial virus subtypes A and B in children with acute respiratory infections in Beijing during 2000 to 2006 seasons].
    Deng J; Qian Y; Zhu RN; Wang F; Zhao LQ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):924-7. PubMed ID: 17254462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
    J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis.
    Cong B; Koç U; Bandeira T; Bassat Q; Bont L; Chakhunashvili G; Cohen C; Desnoyers C; Hammitt LL; Heikkinen T; Huang QS; Markić J; Mira-Iglesias A; Moyes J; Nokes DJ; Ploin D; ; Seo E; Singleton R; Wolter N; Fu Yung C; Zar HJ; Feikin DR; Sparrow EG; ; Nair H; Li Y;
    Lancet Infect Dis; 2024 Apr; 24(4):361-374. PubMed ID: 38141633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: A cohort study.
    Benítez-Guerra D; Piña-Flores C; Zamora-López M; Escalante-Padrón F; Lima-Rogel V; González-Ortiz AM; Guevara-Tovar M; Bernal-Silva S; Benito-Cruz B; Castillo-Martínez F; Martínez-Rodríguez LE; Ramírez-Ojeda V; Tello-Martínez N; Lomelí-Valdez R; Salto-Quintana J; Cadena-Mota S; Noyola DE
    Influenza Other Respir Viruses; 2020 Mar; 14(2):182-188. PubMed ID: 31917902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and associated factors for hospitalization related respiratory syncytial virus infection among children less than 5 years of age in Northern Thailand.
    Chaiut W; Sapbamrer R; Dacha S; Sudjaritruk T; Malasao R
    J Infect Public Health; 2023 Oct; 16(10):1659-1665. PubMed ID: 37633227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.
    Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F
    J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.
    Hall CB; Weinberg GA; Blumkin AK; Edwards KM; Staat MA; Schultz AF; Poehling KA; Szilagyi PG; Griffin MR; Williams JV; Zhu Y; Grijalva CG; Prill MM; Iwane MK
    Pediatrics; 2013 Aug; 132(2):e341-8. PubMed ID: 23878043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical characteristics of hospitalized children with respiratory syncytial virus infection and risk prediction of severe illness during the post-COVID-19 era in Kunming].
    Liu HF; Feng QL; Huang RW; Yuan TY; Sui MZ; Li PL; Liu K; Li F; Li Y; Jiang L; Fu HM
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):323-330. PubMed ID: 38527502
    [No Abstract]   [Full Text] [Related]  

  • 30. SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
    Anderson EJ; DeVincenzo JP; Simões EAF; Krilov LR; Forbes ML; Pannaraj PS; Espinosa CM; Welliver RC; Wolkoff LI; Yogev R; Checchia PA; Domachowske JB; Halasa N; McBride SJ; Kumar VR; McLaurin KK; Rizzo CP; Ambrose CS
    Am J Perinatol; 2020 Mar; 37(4):421-429. PubMed ID: 30991438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing patterns of initial respiratory syncytial virus infection and factors influencing disease severity in hospitalized infants with different health status.
    Shi P; Wang R; Liu E; Deng Y
    J Med Virol; 2024 Jun; 96(6):e29719. PubMed ID: 38873911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation.
    Simões EA; Anderson EJ; Wu X; Ambrose CS
    PLoS One; 2016; 11(11):e0166226. PubMed ID: 27898687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections?
    Stobbelaar K; Mangodt TC; Van der Gucht W; Delhaise L; Andries J; Gille V; Barbezange C; Smet A; De Winter BY; De Dooy JJ; Schepens T; Duval ELIM; Cos P; Jorens PG; Verhulst S; Delputte PL
    Microbiol Spectr; 2023 Jun; 11(3):e0436822. PubMed ID: 37212711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan.
    Khuri-Bulos N; Williams JV; Shehabi AA; Faouri S; Al Jundi E; Abushariah O; Chen Q; Ali SA; Vermund S; Halasa NB
    Scand J Infect Dis; 2010 May; 42(5):368-74. PubMed ID: 20100116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
    Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
    Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the economic burden of respiratory syncytial virus infections in infants in Vietnam: a cohort study.
    Do LAH; Vodicka E; Nguyen A; Le TNK; Nguyen TTH; Thai QT; Pham VQ; Pham TU; Nguyen TN; Mulholland K; Cao MT; Le NTN; Tran AT; Pecenka C
    BMC Infect Dis; 2023 Feb; 23(1):73. PubMed ID: 36747128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
    Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.